Replies to post #329821 on NorthWest Biotherapeutics Inc (NWBO)

[Survivor2012]

"No brag, just fact" (you younger guys may have to look up that quote online -- Walter Brennan -- 1960s)

[Kam8]

Dear ATL, Thanks the amazing post.

[br8k0ut]

"(6) In the UK & Germany, the RAs (MHRA & PEI) are responsible for updating the revised endpoints in the clinical trial register. In the US, NWBio is responsible for updating the revised endpoints in clinical trial register. "



Have any shareholders asked David Innes why they have not updated the clinical trials website yet?

[marzan]

Perfect! Thanks a lot ATLnsider, you are The Man! Thanks for adding Lykiri's post on LP's response to a Q&A when she would data lock at what stage of SAP with the RAs. Very specific question to the current FUD and a very clear response to the current FUD. She said very clearly she would data lock only after all 4 RAs buy-in the SAP. Also thanks for adding FDA's guidance on the MRCT multi regional clinical trial meaning International meaning a trial like DcVaxL conducted in multiple countries where the EndPoint(s) have to be the same. While UK and Germany already reflected and while DI said US one is delayed due to 'clerical' at the Registry side, the pps should fly to $5s so that institutions can load up, but the fudsters are just FUDing. Crystal Clear! They picked on the warrant holders blaming them as diluting and drove down the price from $2.50 to $1 and now all the warrants are pushed back. They have no FUDs to fearmonger. We should see $5s now.

[CherryTree1]

GREAT POST ATLnsider

[BigAl2020]

Amazing post! Thank you for your contributions to this MB.

[extrooper]

Always appreciative of your posts.

[OilPatch]

Thanks ATLnsider

we don't talk about our communications that are ongoing with FDA or other regulators. We only say results,

BOOM!

[learningcurve2020]

How does that square with what The Big Rago said back in Feb. 2019?

>>5. They have stated that they are submitting the Statistical Analysis Plan to four distinct geographical/market regions - This gives them four independent chances at regulatory success and four chances at commercialization/revenue. i.e. the probability of regulatory success in at least one of the four markets is better than the probability of regulatory success if they were to submit to only one market.

[sentiment_stocks]

Thanks for the comprehensive post regarding the SAP “buy-in” by the regulatory agencies! :)

Is there a clinical trial site unique to Canada? I can’t seem to find one. If there is, I doubt that NWBO is responsible for updating it, so I wonder if it’s been updated yet by those who are?

[marzan]

ATLnsider, thanks you have been telling us million times tirelessly that the SAP was bought in by all 4 RAs and it enjoys the MRCT guidance that all 4RAs must bind to. One good thing is the longer the fudsters fear monger on this, the better for us loading cheap shares. In the whole stock market that we have been ever known to mankind, we see this stock is for granted already. It is up to the shorts to dig deeper or cover ASAP. The day traders and swing traders better know what a beast they are dealing with that with no advance warning this thing can raise the floor to 10 times that they lose their trading money in no time and walk home empty hand.

[Flexroy]

Your doing the lord's work brother. Thx for continuing to remind us

[OilPatch]

THIS SHOULD BE A STICKY NOTE.

[highwayman4life]

Thnx for keeping up the good work ATL!

Truth will prevail!

GLTA

[MI Dendream]

I have been trying for the life of me to think about what news over the past 12 months has driven the stock price down from $2.50 to $0.65 and all I can come up with is good news.

I mean ATL here posted a pretty comprehensive review and believe it or not there was even more added in from several angles that ATL did not include.

But there is no way this stock has been manipulated down…no way.